A growing number of prominent health leaders fear that President Donald Trump will legally autorize a vaccine before election day, running roughshod over the usual regulatory process.
Sep 21, 2020
Image
Robert Smith listens as Dr. Vladimir Berthaud speaks with Black patients about participating in clinical trials for a COVID-19 vaccine candidate./Blake Farmer for KHN
So far, participation by minority volunteers in coronavirus trials has increased only slightly compared with the usually low levels in other clinical trials.
The Food and Drug Administration is weighing whether to resume a coronavirus vaccine trial that was halted when a volunteer suffered spinal cord damage as federal health officials launch an investigation.
The nation's top infectious disease expert says If a monitoring board gave the green light, vaccine manufacturers would be obligated to end their trials early and make the shots available.